Twist Bioscience

Yahoo Finance • 8 days ago

Interesting TWST Put And Call Options For November 21st

Investors in Twist Bioscience Corp (Symbol: TWST) saw new options become available this week, for the November 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the TWST options chain for the new No... Full story

Yahoo Finance • 17 days ago

Oversold Conditions For Twist Bioscience (TWST)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the R... Full story

Yahoo Finance • last month

Cathie Wood's ARK ETF bolsters biotech, trims defense stock

Cathie Wood’s ARK ETF published their daily trades for Monday, August 18th, 2025, showcasing a continued focus on the biotech sector while reducing exposure in defense. The largest trade of the day was the purchase of 170,471 shares of Gen... Full story

Yahoo Finance • last month

Cathie Wood's ARK ETF focuses on Roblox and CoreWeave stock buys

Cathie Wood’s ARK ETF released its daily trades for Friday, August 15th, 2025, revealing a series of strategic investments and divestments across various sectors. The largest transaction of the day was the purchase of 125,799 shares of Rob... Full story

Yahoo Finance • last month

[Latest] Global AI in Synthetic Biology Market Size/Share Worth USD 192.95 Billion by 2034 at a 28.63% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Custom Market Insights [220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global AI in Synthetic Biology Market size & share revenue was valued at approximately USD... Full story

Yahoo Finance • 2 months ago

Twist Bioscience earnings beat by $0.86, revenue topped estimates

Investing.com - Twist Bioscience (NASDAQ: TWST) reported third quarter EPS of $0.33, $0.86 better than the analyst estimate of $-0.53. Revenue for the quarter came in at $96.06M versus the consensus estimate of $95.61M. Twist Bioscience’s... Full story

Yahoo Finance • 2 months ago

Twist Bioscience outlines $374M-$376M 2025 revenue target while expanding NGS and SynBio portfolio

Earnings Call Insights: Twist Bioscience (TWST) Q3 2025 MANAGEMENT VIEW * CEO Emily Marine Leproust stated the company added hundreds of new customers and introduced the first in a series of planned SynBio product line expansions, emph... Full story

Yahoo Finance • 2 months ago

Earnings call transcript: Twist Bioscience Q3 2025 sees revenue rise 18%

Twist Bioscience Corp (TWST) reported its Q3 2025 earnings, showing a significant 18% year-over-year increase in revenue, reaching $96.1 million. Despite this growth, the company’s stock saw a decline of 5.58% in premarket trading, with sh... Full story

Yahoo Finance • 2 months ago

Twist Bioscience Corp (NASDAQ:TWST) Reports Mixed Q3 2025 Results with Revenue Miss and EPS Beat

Twist Bioscience Corp. (NASDAQ:TWST [https://www.chartmill.com/stock/quote/TWST/profile]) reported its fiscal third-quarter 2025 financial results, delivering mixed performance relative to analyst expectations. The synthetic DNA manufactur... Full story

Yahoo Finance • 2 months ago

Twist Bioscience Q3 2025 slides: revenue hits $96.1M as margins exceed 50% target

Introduction & Market Context Twist Bioscience (NASDAQ:TWST) released its fiscal third quarter 2025 financial results on August 4, 2025, showcasing continued progress toward profitability with improved margins and reduced losses. The synt... Full story

Yahoo Finance • 2 months ago

Twist Bioscience beats top-line and bottom-line estimates; initiates Q4 and updates FY outlook

* Twist Bioscience press release [https://seekingalpha.com/pr/20187285-twist-bioscience-announces-fiscal-2025-third-quarter-financial-results] (NASDAQ:TWST [https://seekingalpha.com/symbol/TWST]): Q3 GAAP EPS of $0.34 beats by $0.91. *... Full story

Yahoo Finance • 2 months ago

Is Twist Bioscience Corp. (TWST) Nearing Profitability?

Conestoga Capital Advisors, an asset management company, released its second-quarter 2025 investor letter. A copy of the letter can be downloaded here. The second quarter began with a historically poor start but gained momentum later as ta... Full story

Yahoo Finance • 3 months ago

Cathie Wood's ARK ETF adjusts holdings, sells Coinbase, buys Tesla

Cathie Wood’s ARK ETFs have made a series of trades on Friday, June 27, 2025, with a significant sell-off in Coinbase Global Inc (NASDAQ:COIN) and notable purchases including Tesla Inc (NASDAQ:TSLA) and SoFi Technologies Inc (NASDAQ:SOFI... Full story

Yahoo Finance • 3 months ago

Cathie Wood's ARK ETFs shuffle healthcare and tech stock holdings

Cathie Wood’s ARK ETFs have made their daily trades for Wednesday, June 25th, 2025, with a significant focus on healthcare and technology stocks. The trades included both substantial acquisitions and divestitures, reflecting ARK’s ongoing... Full story

Yahoo Finance • 3 months ago

Cathie Wood's ARK ETF trades Shopify, Toast stock amid tech focus

Cathie Wood’s ARK ETFs have revealed their daily trades for Tuesday, June 24th, 2025, with notable activity in the technology sector. ARK’s most significant trades of the day included purchases of Shopify Inc (NYSE:NASDAQ:SHOP) and Toas... Full story

Yahoo Finance • 4 months ago

Cathie Wood's ARK Dumps $26 Million Palantir Shares, Bulks Up on Airbnb

May 16 - Cathie Wood's ARK (ARKK) ETFs shifted their bets in the latest trading session. ARK's flagship ARKK ETF snapped up 214,624 shares of Airbnb Inc (NASDAQ:ABNB), spending about $29.6 million on the home-rental platform. Its ARKF ETF... Full story

Yahoo Finance • 7 months ago

Twist Bioscience Offers Clonal Genes for Global Academic Researchers at Express Speed for No Extra Cost

— Supports Acceleration of Research Across Multiple Industries; Maximizes Budget — SOUTH SAN FRANCISCO, Calif., March 11, 2025--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company i... Full story

Yahoo Finance • 8 months ago

Earnings Update: Twist Bioscience Corporation (NASDAQ:TWST) Just Reported Its First-Quarter Results And Analysts Are Updating Their Forecasts

Twist Bioscience Corporation (NASDAQ:TWST) investors will be delighted, with the company turning in some strong numbers with its latest results. Revenues beat expectations coming in atUS$89m, ahead of estimates by 2.0%. Statutory losses we... Full story

Yahoo Finance • 8 months ago

Gene Synthesis Market Size to Surpass USD 9.54 Billion by 2033 | Straits Research

New York, United States, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Gene synthesis is a synthetic biology technique used in the laboratory to create artificial genes. In contrast to molecular cloning and polymerase chain reactions, this method us... Full story

Yahoo Finance • 2 years ago

Twist Bioscience Corporation (NASDAQ:TWST) Q1 2024 Earnings Call Transcript

Twist Bioscience Corporation (NASDAQ:TWST) Q1 2024 Earnings Call Transcript February 2, 2024 Twist Bioscience Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). O... Full story